BACKGROUND: Possible negative effects, including increased mortality, among persons who receive stored red blood cells (RBCs) have recently garnered considerable attention. Despite many studies, including 4 randomized trials, no consensus exists. OBJECTIVE: To study the association between the length of RBC storage and mortality in a large population-based cohort of patients who received transfusions, allowing detection of small yet clinically significant effects. DESIGN: Binational cohort study. SETTING: All transfusion recipients in Sweden and Denmark. PATIENTS: 854 862 adult patients who received transfusions from 2003 to 2012. MEASUREMENTS: Patients were followed from first blood transfusion. Relative and absolute risks for death in 30 days or 1 year in relation to length of RBC storage were assessed by using 3 independent analytic approaches. All analyses were conducted by using Cox proportional hazards regression. RESULTS: Regardless of the analytic approach, no association was found between the length of RBC storage and mortality. The difference in 30-day cumulative mortality between patients receiving blood stored for 30 to 42 days and those receiving blood stored for 10 to 19 days was -0.2% (95% CI, -0.5% to 0.1%). Even among patients who received more than 6 units of RBCs stored for 30 days or longer, the hazard ratio of death was 1.00 (CI, 0.96 to 1.05) compared with those who received no such units. LIMITATION: Observational study; risk of confounding by indication. CONCLUSION: Consistent with previous randomized trials, this study found no association between the length of storage of transfused RBCs and patient mortality. Results were homogeneous, with differences in absolute mortality consistently less than 1% among the most extreme exposure categories. These findings suggest that the current practice of storing RBCs for up to 42 days does not need to be changed. PRIMARY FUNDING SOURCE: The Swedish Research Council, Swedish Heart-Lung Foundation, Swedish Society for Medical Research, Strategic Research Program in Epidemiology at Karolinska Institutet, and Danish Council for Independent Research.
BACKGROUND: Possible negative effects, including increased mortality, among persons who receive stored red blood cells (RBCs) have recently garnered considerable attention. Despite many studies, including 4 randomized trials, no consensus exists. OBJECTIVE: To study the association between the length of RBC storage and mortality in a large population-based cohort of patients who received transfusions, allowing detection of small yet clinically significant effects. DESIGN: Binational cohort study. SETTING: All transfusion recipients in Sweden and Denmark. PATIENTS: 854 862 adult patients who received transfusions from 2003 to 2012. MEASUREMENTS: Patients were followed from first blood transfusion. Relative and absolute risks for death in 30 days or 1 year in relation to length of RBC storage were assessed by using 3 independent analytic approaches. All analyses were conducted by using Cox proportional hazards regression. RESULTS: Regardless of the analytic approach, no association was found between the length of RBC storage and mortality. The difference in 30-day cumulative mortality between patients receiving blood stored for 30 to 42 days and those receiving blood stored for 10 to 19 days was -0.2% (95% CI, -0.5% to 0.1%). Even among patients who received more than 6 units of RBCs stored for 30 days or longer, the hazard ratio of death was 1.00 (CI, 0.96 to 1.05) compared with those who received no such units. LIMITATION: Observational study; risk of confounding by indication. CONCLUSION: Consistent with previous randomized trials, this study found no association between the length of storage of transfused RBCs and patient mortality. Results were homogeneous, with differences in absolute mortality consistently less than 1% among the most extreme exposure categories. These findings suggest that the current practice of storing RBCs for up to 42 days does not need to be changed. PRIMARY FUNDING SOURCE: The Swedish Research Council, Swedish Heart-Lung Foundation, Swedish Society for Medical Research, Strategic Research Program in Epidemiology at Karolinska Institutet, and Danish Council for Independent Research.
Authors: Stacy M Endres-Dighe; Yuelong Guo; Tamir Kanias; Marion Lanteri; Mars Stone; Bryan Spencer; Ritchard G Cable; Joseph E Kiss; Steve Kleinman; Mark T Gladwin; Donald J Brambilla; Pam D'Andrea; Darrell J Triulzi; Alan E Mast; Grier P Page; Michael P Busch Journal: Transfusion Date: 2018-09-28 Impact factor: 3.157
Authors: Nareg H Roubinian; Colleen Plimier; Jennifer P Woo; Catherine Lee; Roberta Bruhn; Vincent X Liu; Gabriel J Escobar; Steven H Kleinman; Darrell J Triulzi; Edward L Murphy; Michael P Busch Journal: Blood Date: 2019-07-26 Impact factor: 22.113
Authors: Gustaf Edgren; Henrik Ullum; Klaus Rostgaard; Christian Erikstrup; Ulrik Sartipy; Martin J Holzmann; Olof Nyrén; Henrik Hjalgrim Journal: JAMA Intern Med Date: 2017-06-01 Impact factor: 21.873
Authors: Sofie L Rygård; Andreas B Jonsson; Martin B Madsen; Anders Perner; Lars B Holst; Pär I Johansson; Jørn Wetterslev Journal: Intensive Care Med Date: 2018-01-25 Impact factor: 17.440
Authors: Matthew S Karafin; Roberta Bruhn; Matt Westlake; Marian T Sullivan; Walter Bialkowski; Gustaf Edgren; Nareg H Roubinian; Ronald G Hauser; Daryl J Kor; Debra Fleischmann; Jerome L Gottschall; Edward L Murphy; Darrell J Triulzi Journal: Transfusion Date: 2017-10-24 Impact factor: 3.157